INTREPID POTASH INC (IPI) Stock Fundamental Analysis
USA - NYSE:IPI - US46121Y2019 - Common Stock
29.21 USD
+0.04 (+0.14%)
29 USD
-0.21 (-0.72%)
Overall IPI gets a fundamental rating of 4 out of 10. We evaluated IPI against 83 industry peers in the Chemicals industry. While IPI has a great health rating, there are worries on its profitability. While showing a medium growth rate, IPI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
IPI had positive earnings in the past year.
In the past year IPI had a positive cash flow from operations.
In multiple years IPI reported negative net income over the last 5 years.
Each year in the past 5 years IPI had a positive operating cash flow.
1.2 Ratios
IPI's Return On Assets of -33.11% is on the low side compared to the rest of the industry. IPI is outperformed by 90.36% of its industry peers.
IPI has a worse Return On Equity (-41.55%) than 79.52% of its industry peers.
IPI has a Return On Invested Capital of 0.66%. This is in the lower half of the industry: IPI underperforms 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROIC | 0.66% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 1.68%, IPI is not doing good in the industry: 74.70% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 15.54%, IPI is doing worse than 73.49% of the companies in the same industry.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IPI is destroying value.
IPI has more shares outstanding than it did 1 year ago.
IPI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IPI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.34 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
IPI has a Altman-Z score of 2.34. This is in the better half of the industry: IPI outperforms 63.86% of its industry peers.
IPI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
IPI has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. IPI outperforms 98.80% of its industry peers.
IPI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, IPI belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 2.34 |
ROIC/WACC0.07
WACC9.1%
2.3 Liquidity
A Current Ratio of 5.28 indicates that IPI has no problem at all paying its short term obligations.
IPI has a Current ratio of 5.28. This is amongst the best in the industry. IPI outperforms 93.98% of its industry peers.
IPI has a Quick Ratio of 2.78. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.78, IPI belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 |
3. Growth
3.1 Past
IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 151.75%, which is quite impressive.
The Revenue has grown by 11.91% in the past year. This is quite good.
The Revenue has been growing slightly by 2.96% on average over the past years.
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
3.2 Future
The Earnings Per Share is expected to grow by 0.78% on average over the next years.
The Revenue is expected to grow by 0.32% on average over the next years.
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y-0.1%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 49.51, IPI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, IPI is valued a bit more expensive than the industry average as 65.06% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of IPI to the average of the S&P500 Index (27.30), we can say IPI is valued expensively.
The Forward Price/Earnings Ratio is negative for IPI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.51 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IPI is valued cheaply inside the industry as 83.13% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IPI is valued a bit cheaper than 78.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.12 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y0.78%
5. Dividend
5.1 Amount
No dividends for IPI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.21
+0.04 (+0.14%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners56.05%
Inst Owner Change0.96%
Ins Owners2%
Ins Owner Change-0.05%
Market Cap389.08M
Analysts42.22
Price Target23.46 (-19.69%)
Short Float %2.52%
Short Ratio1.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)598.3%
Min EPS beat(2)324.33%
Max EPS beat(2)872.28%
EPS beat(4)2
Avg EPS beat(4)261.99%
Min EPS beat(4)-142.02%
Max EPS beat(4)872.28%
EPS beat(8)2
Avg EPS beat(8)-89.19%
EPS beat(12)2
Avg EPS beat(12)-70.18%
EPS beat(16)3
Avg EPS beat(16)-55.32%
Revenue beat(2)2
Avg Revenue beat(2)21.74%
Min Revenue beat(2)17.42%
Max Revenue beat(2)26.05%
Revenue beat(4)4
Avg Revenue beat(4)20.54%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)22.42%
Revenue beat(12)11
Avg Revenue beat(12)21.59%
Revenue beat(16)15
Avg Revenue beat(16)18.93%
PT rev (1m)-4.17%
PT rev (3m)9.52%
EPS NQ rev (1m)247.06%
EPS NQ rev (3m)247.06%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)9.31%
Revenue NQ rev (3m)9.31%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.51 | ||
| Fwd PE | N/A | ||
| P/S | 1.38 | ||
| P/FCF | 15.12 | ||
| P/OCF | 7.19 | ||
| P/B | 0.8 | ||
| P/tB | 0.84 | ||
| EV/EBITDA | 6.85 |
EPS(TTM)0.59
EY2.02%
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)1.93
FCFY6.61%
OCF(TTM)4.06
OCFY13.9%
SpS21.22
BVpS36.32
TBVpS34.69
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROCE | 0.84% | ||
| ROIC | 0.66% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 0.81% | ||
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% | ||
| FCFM | 9.11% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 71.13% | ||
| Cap/Sales | 10.03% | ||
| Interest Coverage | 10.72 | ||
| Cash Conversion | 121.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 2.34 |
F-Score4
WACC9.1%
ROIC/WACC0.07
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
Revenue Next Year2.36%
Revenue Next 2Y-0.1%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
EBIT growth 1Y129.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1675.2%
EBIT Next 3Y142.16%
EBIT Next 5YN/A
FCF growth 1Y159.44%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y21.52%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%